Skip to main content

Table 1 Characteristics of recorded isolates in each participating hospital

From: Emergence of a mupirocin-resistant, methicillin-susceptible Staphylococcus aureus clone associated with skin and soft tissue infections in Greece

  2014 2015 2016 2017 2018 TOTAL
UGHP PAKCH UGHL UGHP PAKCH UGHL UGHP PAKCH UGHL UGHP PAKCH UGHL UGHP PAKCH UGHL  
Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%)
SSTIs 1111 335 697 1112 384 789 1443 509 986 1527 543 905 1505 511 887 13244
SA 388 (34.9) 279 (83.3) 254 (36.4) 477 (42.9) 337 (87.8) 335 (42.5) 635 (44.0) 433 (85.1) 384 (38.9) 543 (35.6) 470 (86.6) 378 (41.8) 536 (35.6) 445 (87.1) 251 (28.3) 6145 (46.4)
MSSA 246 (63.4) 211 (75.6) 157 (61.8) 347 (72.7) 274 (81.3) 198 (59.1) 527 (83) 379 (87.5) 243 (63.3) 468 (86.2) 430 (91.5) 240 (63.5) 519 (96.8) 390 (87.6) 177 (70.5) 4806 (78.2)
MUP-R 15 (6.1) 74 (35.1) 12 (7.6) 51 (14.7) 107 (39.1) 23 (11.6) 128 (24.3) 230 (60.7) 38 (15.6) 89 (19) 316 (73.5) 35 (14.6) 92 (17.7) 245 (62.8) 29 (16.4) 1484 (30.9)
MA 5 (33.3) 10 (13.5) 5 (41.7) 18 (35.3) 10 (9.3) 8 (34.8) 38 (29.7) 25 (10.9) 15 (39.5) 26 (29.2) 36 (11.4) 11 (31.4) 23 (25.0) 22 (9.0) 8 (27.6) 260 (17.5)
  1. SA S. aureus from recorded SSTIs, MSSA Methicillin-susceptible isolates among S. aureus, MUP-R mupirocin-resistant strains among MSSA, MA molecularly analyzed strains